Ellab continues acquisition spree with Dutch target

Lab firm Ellab has made its tenth acquisition in three years by taking over a firm which measures the effectiveness of disinfection and sterilization machines.

Photo: Ellab / PR

Ellab has acquired Causa, a firm which offers validation services specializing in disinfection and sterlization equipment for the pharmaceutical industry. Causa is based in the Netherlands.

This is Ellab’s tenth acquisition since 2019.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs